// App-Quantinova.ai

BSH19‐OR‐004 : Targeting H3K9me3 as novel therapeutic strategy in MLLr‐AML

Researchers

Presenter

  • M.E. Massett

Principal Investigators

  • A.M. Michie

  • D. Vetrie

  • X. Huang

Medical Centers

  • Paul O'Gorman Leukaemia Research Centre, University of Glasgow

  • Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Cluster of Differentiation 34

  • Protein AF-9

  • DNA methyltransferase 3 alpha

  • Histone-lysine N-methyltransferase 2A

  • Isocitrate dehydrogenase 1

  • Tet methylcytosine dioxygenase 2

  • Trimethylation of lysine 27 on histone H3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved